BlackRock Fund Advisors - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 14 filers reported holding EVOKE PHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q4 2016$63,000
+5.0%
31,132
+16.6%
0.00%
Q3 2016$60,000
-27.7%
26,700
+120.8%
0.00%
Q2 2016$83,000
+1560.0%
12,092
+1231.7%
0.00%
Q1 2016$5,000
+150.0%
908
+20.4%
0.00%
Q4 2015$2,0007540.00%
Other shareholders
EVOKE PHARMA INC shareholders Q4 2015
NameSharesValueWeighting ↓
Wambolt & Associates, LLC 32,000$150,0000.11%
SABBY MANAGEMENT, LLC 22,382$105,0000.02%
Cetera Advisor Networks LLC 30,260$142,0000.00%
COMMONWEALTH EQUITY SERVICES, LLC 32,387$151,0000.00%
Creative Planning 100,000$469,0000.00%
Dorsey Wright & Associates 1,604$8,0000.00%
Lindbrook Capital, LLC 1,000$5,0000.00%
NORTHERN TRUST CORP 37,227$175,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 10,057$47,0000.00%
View complete list of EVOKE PHARMA INC shareholders